Liquidia (LQDA) Operating Income (2020 - 2026)
Liquidia (LQDA) recorded quarterly Operating Income of $61.5 million in Q1 2026, up 210.83% quarter-over-quarter from $19.8 million in Q4 2025, and up 273.62% on a YoY basis from $16.5 million in Q1 2025.
Liquidia (LQDA) Operating Income (2020 - 2026) Analysis & Trends
Liquidia's Operating Income history runs 7 years deep, the most recent figure standing at $61.5 million for Q1 2026.
- In Q1 2026, Operating Income rose 273.62% year-over-year to $61.5 million; the TTM figure through Mar 2026 stood at $45.6 million (up 135.61% YoY), while the FY2025 annual figure was -$51.4 million, up 57.64% from the prior year.
- Operating Income was $61.5 million for Q1 2026 at Liquidia, up from $19.8 million in the prior quarter.
- In the past five years, Operating Income ranged from a high of $61.5 million in Q1 2026 to a low of -$37.5 million in Q2 2025.
- Historically, Operating Income has averaged -$13.1 million across 5 years, with a median of -$14.9 million in 2023.
- The sharpest annual moves came in 2023 and 2026: Operating Income sank 306.9% in 2023, then surged 273.62% in 2026.
- A 5-year view of Operating Income shows it stood at -$6.5 million in 2022, then tumbled by 306.9% to -$26.4 million in 2023, then sank by 36.58% to -$36.1 million in 2024, then surged by 154.8% to $19.8 million in 2025, then jumped by 210.83% to $61.5 million in 2026.
- The last three Operating Income figures came in at $61.5 million (Q1 2026), $19.8 million (Q4 2025), and $1.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 652.00 Mn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | 833.00 Mn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 325.80 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 14.03 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 193.40 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | 307.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | -48.28 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 81.33 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | -78.32 Mn |
| 10 | Liquidia | 5.74 Bn | 5.52 Bn | 121.79 Mn | 61.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 61.50 Mn |
| Dec 31, 2025 | 19.79 Mn |
| Sep 30, 2025 | 1.77 Mn |
| Jun 30, 2025 | -37.51 Mn |
| Mar 31, 2025 | -35.43 Mn |
| Dec 31, 2024 | -36.11 Mn |
| Sep 30, 2024 | -29.19 Mn |
| Jun 30, 2024 | -27.20 Mn |
| Mar 31, 2024 | -28.80 Mn |
| Dec 31, 2023 | -26.44 Mn |
| Sep 30, 2023 | -14.89 Mn |
| Jun 30, 2023 | -22.83 Mn |
| Mar 31, 2023 | -9.23 Mn |
| Dec 31, 2022 | -6.50 Mn |
| Sep 30, 2022 | -8.83 Mn |
| Jun 30, 2022 | -8.97 Mn |
| Mar 31, 2022 | -14.47 Mn |
| Dec 31, 2021 | -11.36 Mn |
| Sep 30, 2021 | -7.08 Mn |
| Jun 30, 2021 | -6.35 Mn |